244 related articles for article (PubMed ID: 29041824)
1. A new nanoemulsion formulation improves antileishmanial activity and reduces toxicity of amphotericin B.
Santos DCMD; de Souza MLS; Teixeira EM; Alves LL; Vilela JMC; Andrade M; Carvalho MDG; Fernandes AP; Ferreira LAM; Aguiar MMG
J Drug Target; 2018 Apr; 26(4):357-364. PubMed ID: 29041824
[TBL] [Abstract][Full Text] [Related]
2. Nanoemulsions loaded with amphotericin B: a new approach for the treatment of leishmaniasis.
Caldeira LR; Fernandes FR; Costa DF; Frézard F; Afonso LC; Ferreira LA
Eur J Pharm Sci; 2015 Apr; 70():125-31. PubMed ID: 25660615
[TBL] [Abstract][Full Text] [Related]
3. Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes.
Prajapati VK; Awasthi K; Gautam S; Yadav TP; Rai M; Srivastava ON; Sundar S
J Antimicrob Chemother; 2011 Apr; 66(4):874-9. PubMed ID: 21393222
[TBL] [Abstract][Full Text] [Related]
4. Bovine serum albumin nanoparticles containing amphotericin B were effective in treating murine cutaneous leishmaniasis and reduced the drug toxicity.
Casa DM; Scariot DB; Khalil NM; Nakamura CV; Mainardes RM
Exp Parasitol; 2018 Sep; 192():12-18. PubMed ID: 30026113
[TBL] [Abstract][Full Text] [Related]
5. Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin B.
Larabi M; Yardley V; Loiseau PM; Appel M; Legrand P; Gulik A; Bories C; Croft SL; Barratt G
Antimicrob Agents Chemother; 2003 Dec; 47(12):3774-9. PubMed ID: 14638481
[TBL] [Abstract][Full Text] [Related]
6. Bioinspired Calcium Phosphate Nanoparticles Featuring as Efficient Carrier and Prompter for Macrophage Intervention in Experimental Leishmaniasis.
Chaurasia M; Singh PK; Jaiswal AK; Kumar A; Pawar VK; Dube A; Paliwal SK; Chourasia MK
Pharm Res; 2016 Nov; 33(11):2617-29. PubMed ID: 27401407
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol improves stability of amphotericin B nanoemulsion: promising use in the treatment of cutaneous leishmaniasis.
Mansur-Alves I; Lima BLF; Santos TT; Araújo NF; Frézard F; Islam A; de Barros AL; Dos Santos DC; Fernandes C; Ferreira LA; Aguiar MM
Nanomedicine (Lond); 2022 Aug; 17(18):1237-1251. PubMed ID: 36189757
[No Abstract] [Full Text] [Related]
8. Synergistic enhancement of parasiticidal activity of amphotericin B using copaiba oil in nanoemulsified carrier for oral delivery: an approach for non-toxic chemotherapy.
Gupta PK; Jaiswal AK; Asthana S; Teja B V; Shukla P; Shukla M; Sagar N; Dube A; Rath SK; Mishra PR
Br J Pharmacol; 2015 Jul; 172(14):3596-610. PubMed ID: 25825339
[TBL] [Abstract][Full Text] [Related]
9. Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres.
Sánchez-Brunete JA; Dea MA; Rama S; Bolás F; Alunda JM; Raposo R; Méndez MT; Torrado-Santiago S; Torrado JJ
Antimicrob Agents Chemother; 2004 Sep; 48(9):3246-52. PubMed ID: 15328080
[TBL] [Abstract][Full Text] [Related]
10. Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.
Gangneux JP; Sulahian A; Garin YJ; Farinotti R; Derouin F
Antimicrob Agents Chemother; 1996 May; 40(5):1214-8. PubMed ID: 8723469
[TBL] [Abstract][Full Text] [Related]
11. Lipid formulations of amphotericin b in the treatment of experimental visceral leishmaniasis due to Leishmania infantum.
Gangneux JP; Sulahian A; Garin YJ; Derouin F
Trans R Soc Trop Med Hyg; 1996; 90(5):574-7. PubMed ID: 8944278
[TBL] [Abstract][Full Text] [Related]
12. In-vitro and in-vivo antileishmanial activity of inexpensive Amphotericin B formulations: Heated Amphotericin B and Amphotericin B-loaded microemulsion.
Rochelle do Vale Morais A; Silva AL; Cojean S; Balaraman K; Bories C; Pomel S; Barratt G; do Egito EST; Loiseau PM
Exp Parasitol; 2018 Sep; 192():85-92. PubMed ID: 30075233
[TBL] [Abstract][Full Text] [Related]
13. Amphotericin B-loaded nanoparticles for local treatment of cutaneous leishmaniasis.
Abu Ammar A; Nasereddin A; Ereqat S; Dan-Goor M; Jaffe CL; Zussman E; Abdeen Z
Drug Deliv Transl Res; 2019 Feb; 9(1):76-84. PubMed ID: 30484256
[TBL] [Abstract][Full Text] [Related]
14. Nanoemulsions Loaded with Amphotericin B: Development, Characterization and Leishmanicidal Activity.
Araújo GMF; Barros ARA; Oshiro-Junior JA; Soares LF; da Rocha LG; de Lima ÁAN; da Silva JA; Converti A; Damasceno BPGL
Curr Pharm Des; 2019; 25(14):1616-1622. PubMed ID: 31298163
[TBL] [Abstract][Full Text] [Related]
15. Self assembled ionically sodium alginate cross-linked amphotericin B encapsulated glycol chitosan stearate nanoparticles: applicability in better chemotherapy and non-toxic delivery in visceral leishmaniasis.
Gupta PK; Jaiswal AK; Asthana S; Verma A; Kumar V; Shukla P; Dwivedi P; Dube A; Mishra PR
Pharm Res; 2015 May; 32(5):1727-40. PubMed ID: 25425053
[TBL] [Abstract][Full Text] [Related]
16. Chitosan-assisted immunotherapy for intervention of experimental leishmaniasis via amphotericin B-loaded solid lipid nanoparticles.
Jain V; Gupta A; Pawar VK; Asthana S; Jaiswal AK; Dube A; Chourasia MK
Appl Biochem Biotechnol; 2014 Oct; 174(4):1309-1330. PubMed ID: 25106894
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the potential of polyester nanoparticles for per oral delivery of amphotericin B in treating visceral leishmaniasis.
Italia JL; Kumar MN; Carter KC
J Biomed Nanotechnol; 2012 Aug; 8(4):695-702. PubMed ID: 22852479
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
[TBL] [Abstract][Full Text] [Related]
19. Characterization and evaluation of amine-modified graphene amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies.
Mudavath SL; Talat M; Rai M; Srivastava ON; Sundar S
Drug Des Devel Ther; 2014; 8():1235-47. PubMed ID: 25214767
[TBL] [Abstract][Full Text] [Related]
20. Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis.
Reis TAR; Oliveira-da-Silva JA; Tavares GSV; Mendonça DVC; Freitas CS; Costa RR; Lage DP; Martins VT; Machado AS; Ramos FF; Silva AM; Ludolf F; Antinarelli LMR; Brito RCF; Chávez-Fumagalli MA; Humbert MV; Roatt BM; Coimbra ES; Coelho EAF
Exp Parasitol; 2021 Feb; 221():108059. PubMed ID: 33338468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
